SIM
YARW

Spark Investment Management’s Yarrow Bioscience YARW Stock Holding History

Spark Investment Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14
Closed -$394K – 712
2019
Q1 		$394K Buy
14
+1
+8% +$24K 0.02% 425
2018
Q4 		$187K Buy
+13
New +$291K 0.01% 505

Other funds holding YARW

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Spark Investment Management's YARW Position: Q2 2019 in Review

Spark Investment Management sold out of Yarrow Bioscience (YARW) in Q2 2019, closing a stake of 14 shares — an estimated $394K sold.

Spark Investment Management first reported a position in YARW in Q4 2018 and held it in 2 quarters. The position peaked at $394K in Q1 2019. 52 funds tracked by Wall St. Rank hold YARW as of Q2 2019.

  • Spark Investment Management reported no remaining Yarrow Bioscience position as of Q2 2019 after selling out during the quarter.
  • Spark Investment Management sold 14 Yarrow Bioscience shares in Q2 2019, an estimated $394K.
  • Spark Investment Management first reported a position in Yarrow Bioscience in Q4 2018 and held it in 2 quarters.
  • Spark Investment Management's Yarrow Bioscience position peaked at $394K in Q1 2019.
  • 52 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2019.

Based on Spark Investment Management's 13F filing for Q2 2019, filed 12 Aug 2019.